Stanford University bioengineers are developing a faster-acting formulation of insulin that can help diabetes patients better regulate their blood sugar levels.
Researchers have discovered a protein signal that promotes the growth of collateral arteries, which can provide backup if major arteries are blocked.
Later this week, thought-leaders from academia, information technology corporations, venture capital firms, the U.S. government and foundations will convene for the Big Data in Biomedicine …
During the 2014 Big Data in Biomedicine conference, Stanford bioengineer and geneticist Russ Altman, MD, PhD, spoke about the possibility of collecting data directly from …
At last year's Big Data in Biomedicine conference, Stanford geneticist Carlos Bustamante, PhD, spoke about the potential of using genetic information to answer fundamental questions …
Last spring, in a blog post on a study from Stanford systems-medicine chief Atul Butte, MD, PhD, National Institutes of Health Director Francis Collins, MD, PhD, noted that …
